Back to Search
ABRAHAM KORMAN, M.D.
M.D.
Dermatology Physician
NPI: 1255863809IndividualAccepts Medicare
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
35.140976(OH)
CMS Specialties
PrimaryDERMATOLOGY
Education
UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE
Class of 2017
Research & Publications (19)
PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells.
PMID 19651643·Int Immunol·2009
8-other
Cell survival and chromosomal aberrations in CHO-K1 cells irradiated by carbon ions.
PMID 18676154·Appl Radiat Isot·2009
7-preclinical
Anti-programmed death-1 synergizes with granulocyte macrophage colony-stimulating factor--secreting tumor cell immunotherapy providing therapeutic benefit to mice with established tumors.
PMID 19208793·Clin Cancer Res·2009
7-preclinical
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti-CTLA-4 antibodies.
PMID 19581407·J Exp Med·2009
7-preclinical
Biological effectiveness of (12)C and (20)Ne ions with very high LET.
PMID 18979317·Int J Radiat Biol·2008
7-preclinical
High-programmed death-1 levels on hepatitis C virus-specific T cells during acute infection are associated with viral persistence and require preservation of cognate antigen during chronic infection.
PMID 19050238·J Immunol·2008
4-observational
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients.
PMID 18287062·Proc Natl Acad Sci U S A·2008
3-trial
Programmed death-1 blockade enhances expansion and functional capacity of human melanoma antigen-specific CTLs.
PMID 17898045·Int Immunol·2007
8-other
Enhanced protein production by engineered zinc finger proteins.
PMID 17171718·Biotechnol Bioeng·2007
7-preclinical
An irradiation facility with a horizontal beam for radiobiological studies.
PMID 17169947·Radiat Prot Dosimetry·2006
8-other
Principles and use of anti-CTLA4 antibody in human cancer immunotherapy.
PMID 16464564·Curr Opin Immunol·2006
6-review
Tumor immunotherapy: preclinical and clinical activity of anti-CTLA4 antibodies.
PMID 15988909·Curr Opin Investig Drugs·2005
6-review
Impact of an electronic antibiotic advice and approval system on antibiotic prescribing in an Australian teaching hospital.
PMID 15115423·Med J Aust·2004
8-other
Activity and safety of CTLA-4 blockade combined with vaccines in cynomolgus macaques.
PMID 14634142·J Immunol·2003
7-preclinical
Spotted fever group rickettsiae in ticks from the Masai Mara region of Kenya.
PMID 12812343·Am J Trop Med Hyg·2003
7-preclinical
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients.
PMID 12682289·Proc Natl Acad Sci U S A·2003
3-trial
Efficacy of 1% permethrin for the treatment of head louse infestations among Kosovar refugees.
PMID 11011544·Mil Med·2000
7-preclinical
Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4.
PMID 10925287·J Immunol·2000
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 540 OFFICENTER PL STE 240
COLUMBUS, OH 43230 - Phone
- (614) 293-1707
Quick Facts
- NPI
- 1255863809
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 9
- Publications
- 19
Are you this provider?
Claim Your Profile